This document discusses optimizing usability in pharmaceutical R&D processes and technology through a human factors approach. It describes how the traditional linear drug development model is changing, with more parallel pathways and stakeholders involved. Applying human factors principles can help manage risks around usability, errors, safety, and productivity. These principles include considering the human/technical system interaction, conducting task and error analyses, and ensuring processes adapt to human capabilities and limitations. Taking a human-centered approach treats employees and external stakeholders holistically and aims to create meaningful and socially responsible organizations.
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
Human Factors and Medicine Safety
1. Human Factors
Optimising the usability of
processes and technology in
Pharma R&D
Andrew
Alexander
Parsons
MSc, PhD
www.reciprocalminds.com
5th Annual
Pharmacovigilanc
e Forum
2 March 2017
Berlin
3. Medicines Life Cycle – Traditional
View
Discovery Preclinical Phase 1 Phase 2 Phase 3 Phase 4
• Described as a linear process
• High attrition
• High costs in Operation
• Sales drive further innovation
• (high cost due to attrition)
• Long cycle times - 10-20 years
• Many Risks and uncertainties
Favourable
Scientific and
Regulatory
Environment
Cost
effective
use of
Medicine
Societ
al
Value
Innovat
ive
New
Drugs
R&D
Adequ
ate
cash
Flow
Sales
4. Changing Times and New Directions
• Stem cell therapies
• Gene therapies
• Epi-genetic modulation
• Focus on Orphan Disease
• Limited Patient Numbers
• Parallel development (e.g. cancer)
• Disaggregation of the industry
• Small R&D companies supported by CRO and CMOs
• Several Stakeholders in managing supply and operations
A linear model no longer describes the system!
5. • Andrew A Parsons
• Allison Morgan
• Simon Whiteley
• Crystal Ruff
• Ralph Hibbard
Education and Training
Human Centred Organisations
• Brian Edwards
• Fiona Day
• Julia Mironova
Pharma HuF has several Teams
Systems Mapping Sub Team Pharma Huf
7. What are Human Factors?
• Capability depends on combination of interacting elements
• Operation of equipment and systems in circumstances of
fatigue, hunger, stress and even fear
• Usability in demanding circumstances will determine success
• Named roles in Human Factor integration in product life cycle
Learning from Ministry of Defence UK
8. Human Factors
• Is a risk management process – particularly around usability
engineering
• Proactively manages all elements of the process
• Application description
• Requirements specifications
• System design
• Implementation
9. The Process & Environment:
Where conditions matter…
Chemistry
Reagent 1 + Reagent 2 Product 1 + Product
2
Innovation
People + Technology Product + Value
Catalyst
Process Conditions
Socio-Techno Process
(e.g. Safety, Quality, Usability)
Investment
11. System Control Points
Quality
Safe and Effective Medicines
Organisatio
n focus
Product or
Medicine
focus
ValueCost
Individual focus
Team
focus
Safety
Buying
Delivering
Doing
12. High Level System Control Points
Clinical
Safety
Clinical
Effectiven
ess
Manageme
nt and
Process
use-ability
Health and
Safety
Distribution
/ supply of
Product
Manufactur
e
Product
Use-
ability
Commerci
al Value
Payer
Value
HCP
Value
Product or
Medicine focus
Individual focus
Patient
Value
Societal
Value
Management
and Process
Effectiveness
Compensation
and reward
Process
Extrinsic
Motivation
Intrinsic
Motivation
Abilities
Autonom
y
Political
factors
Environmen
tal factors
Financial
factors
Societal
factors
Manageme
nt and
Process
use-ability
Health and
Safety
Team focus
Management
and Process
Effectiveness
Compensation
and reward
Process
Political
factors
Environmental
factors
Financial
factors
Societal
factors
Perception
Bias /
Heuristic
s
Organisation
focus
Safe and Effective Medicines
13. Illustrative Example: Weighting of
decisions in each phase
0
1
2
3
4
5
clinical safety
clinical…
payer value
manufacture
product…
commercial…
patient value
HCP value
societal value
Distribution/P…
Health and…
Mangement…
political factors
financial factors
managemnt…
compensatio…
environmenta…
societal factors
intrinsic…
extrinsic…
perception
abilities
autonomy
bias/heuristics
preclinical
0
1
2
3
4
clinical safety
clinical…
payer value
manufacture
product userbaiity
commercial value
patient value
HCP value
societal value
Distribution/Pro…
Health and Safety
Mangement…
political factors
financial factors
managemnt…
compensation…
environmental…
societal factors
intrinsic…
extrinsic…
perception
abilities
autonomy
bias/heuristics
phase 1
phase 1
0
1
2
3
4
5
clinical safety
clinical…
payer value
manufacture
product…
commercial…
patient value
HCP value
societal value
Distribution/P…
Health and…
Mangement…
political factors
financial factors
managemnt…
compensatio…
environmenta…
societal factors
intrinsic…
extrinsic…
perception
abilities
autonomy
bias/heuristics
phase 2
phase 2
0
1
2
3
4
5
clinical safety
clinical…
payer value
manufacture
product userbaiity
commercial value
patient value
HCP value
societal value
Distribution/Pro…
Health and Safety
Mangement…
political factors
financial factors
managemnt…
compensation…
environmental…
societal factors
intrinsic…
extrinsic…
perception
abilities
autonomy
bias/heuristics
phase 3
phase 3
0
1
2
3
4
5
clinical safety
clinical…
payer value
manufacture
product…
commercial value
patient value
HCP value
societal value
Distribution/Pro…
Health and…
Mangement…
political factors
financial factors
managemnt…
compensation…
environmental…
societal factors
intrinsic…
extrinsic…
perception
abilities
autonomy
bias/heuristics
phase 4
phase 4
14. Steering Ctte
Party A Party B
Program Team
Development
Project Team
Define and Decide
Where, What, How
Who Decides
Transparency of Risks
Communicate
Alignment of Purpose
Meaning rather than perceptions
Governance and Commissioning
15. • Tracking lag measures – reactive and ‘out of control’.
• Focus on the process (Lead) measures
• Ensure Congruence of lag and lead measures
Performance Measures
16. Use failure and effects analysis
• Lots of different risk management plans for when stuff does not
work
• Focus of human safety analysis is SAFETY
• Process of assessment is
• 1 – task analysis
• 2 – PCA analysis (Perception, cognitive and action)
• 3- use error analysis
• Protocol evaluation
17. Managing usability risks
• Task analysis - to each user error and how it is linked to PCA
Risk mitigation is
• Design – changes made to the design
• Protection – protective barrier put in place
• Information – changes to the instructions for use (training) –
seen as weakest
HF focus: how to ensure the system can adapt to the
human error
18. Being Human Centred
Recognition that organisations have impact on customers and
employees, their families and the wider community
It is an approach to integrate a social-technical methodologies and
manage the complex risks of business today e.g.
• Wasted effort, poor efficiency, effectiveness and satisfaction
• Errors and system failures, product recalls…
• Absenteeism, presenteeism, poor recruitment and retention
• Litigation, reputational damage
• Etc….
19. Putting Human Factors First –
Principles
• Capitalise on individual differences as an organisational
strength
• Make usability and accessibility strategic business objectives
• Adopt a total systems approach
• Ensure health, safety and wellbeing are business priorities
• Value employees and create meaningful work environments
• Be open and trustworthy and act in socially responsible ways
ISO 275000 Human Centred Organisations
20. Can you help?
• Led by safety and HF Professionals Lee Allford and Shama
Didla
• Aim to create “best practice” stories for the industry
• Can you share?
• Would you like to learn more?
Pharma Huf ISO27500 Workstream
21. • Use design thinking
• Think systems and human
factors
• Describe the solution state
• Remember you get what you
measure
• Lead and Lag measures
• What we do
• How we do it
Clear strategy, tactics and
operations
How to change effectively